Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naïve Patients with Open-Angle Glaucoma.

Saved in:
Bibliographic Details
Title: Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naïve Patients with Open-Angle Glaucoma.
Authors: Okeke CO; Virginia Eye Consultants/CVP, Norfolk, VA, USA. iglaucoma@gmail.com., Burstein ES; Connecticut Eye Consultants/Danbury Eye Physicians and Surgeons, Danbury, CT, USA., Trubnik V; OCLI, Manhasset, NY, USA., Deom JE; Hazleton Eye Specialists, Hazle Township, PA, USA., Cooper MS; Solinsky EyeCare, West Hartford, CT, USA., Brinkley DA; Eye Specialty Group, Memphis, TN, USA., Thimons JJ; Ophthalmic Consultant of Connecticut, Fairfield, CT, USA., Kabiri AJ; Malik Eye Associates, Manhattan, NY, USA., Gelb KM; Contact Lens and Vision, Woodbridge, NJ, USA.
Source: Ophthalmology and therapy [Ophthalmol Ther] 2020 Dec; Vol. 9 (4), pp. 1041-1053. Date of Electronic Publication: 2020 Oct 07.
Publication Type: Journal Article
Journal Info: Publisher: Springer Healthcare Country of Publication: England NLM ID: 101634502 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8245 (Print) NLM ISO Abbreviation: Ophthalmol Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2193-8245
DOI:10.1007/s40123-020-00307-0